Wall Street Breakfast Fox's FanDuel boon
12 snips
Jan 5, 2026 Fox explores a significant opportunity with an 18.6% stake in FanDuel as Lachlan Murdoch prepares for a strategic move. Meanwhile, LifeMD and GoodRx introduce the newly available once-daily Wegovy pill. The tech scene heats up with Amazon's rollout of Alexa.com and its advanced features. In sports, Manchester United faces managerial upheaval again, while industry expert Howard Marks questions if the AI craze resembles past market bubbles.
AI Snips
Chapters
Transcript
Episode notes
Fox's Valuable FanDuel Option
- Fox holds a long-dated option to acquire 18.6% of FanDuel, effectively turning an earlier Stars stake into a major upside bet.
- Analysts view the option as hidden asset value and a clear positive for Fox's valuation.
Murdoch Signals Intent To Exercise
- Lachlan Murdoch has said Fox fully intends to exercise the FanDuel option and is working with regulators on licensing.
- Market consensus treats the option as a material, realizable asset tied to a FanDuel valuation near $35 billion.
Wagovi Pill Shakes Up Retailers
- Novo Nordisk launched Wegovy's once-daily oral GLP-1 pill, Wagovi, priced at $149/month for cash customers.
- LifeMD and GoodRx rose after adding Wagovi to their offerings, showing immediate market impact on retailers and telehealth firms.